Oral ibuprofen for patent ductus arteriosus closure in preterm infants: Does high osmolality matter?

American Journal of Perinatology

Volumn 25, Issue 5, 2008, Pages 319-320

  Pereira da Silva, Luis ^a   Pita, Ana ^a   Virella, Daniel ^a   Serelha, Micaela ^a  

^a HOSPITAL DONA ESTEFÂNIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CALPROFEN; IBUM; IBUPROFEN; IBUPROFEN LYSINE; IPREN; SOLVENT; WATER;

CALCULATION; DILUTION; EUROPE; FREEZING; LETTER; OSMOLALITY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; SOLUTE; SUSPENSION; UNITED STATES; VARIANCE;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUCTUS ARTERIOSUS, PATENT; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; OSMOLAR CONCENTRATION;

EID: 44849122925     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1075035     Document Type: Letter

References (17)

1. Cherif A, Jabnoun S, Khrouf N. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Am J Perinatol 2007;24:339-345
2. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. Am J Perinatol 2007;24:267-270
3. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 2003;86(Suppl 3):S563-S569
4. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai 2002;85(Suppl 4):S1252-S1258
5. Coombs RC, Morgan ME, Durbin GM, Booth IW, McNeish AS. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990;65:1067-1071
6. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999;135:733-738
7. Rugolotto S, Gruber M, Solano PD, Chini L, Gobbo S, Pecori S. Necrotizing enterocolitis in a 850 gram infant receiving sorbitol-free sodium polystyrene sulfonate (Kayexalate): clinical and histopathologic findings. J Perinatol 2007;27:247-249
8. American Academy of Pediatrics, Committee on Nutrition.. Commentary on breast-feeding and infant formulas included proposed standard formulas. Pediatrics 1976;57:278-285
9. Pereira-da-Silva L, Henriques G, Videira-Amaral JM, Rodrigues R, Ribeiro L, Virella D. Osmolality of solutions, emulsions and drugs that may have a high osmolality: aspects of their use in neonatal care. J Matern Fetal Neonatal Med 2002;11:333-338
10. Warhol RM, Eichenholz A, Mulhausen RO. Osmolality. Arch Intern Med 1965;116:743-749
11. Hariprasad P, Sundarrajan V, Srimathy G, Suthagar B, Ramadevi BS. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatr 2002;39:99-100
12. Sharma PK, Garg SK, Narang A. Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol 2003;43:968-973
13. Tatli MM, Kumral A, Duman N, Demir K, Gurcu O, Ozkan H. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants. Acta Paediatr 2004;93:999-1001
14. Sangtawesin V, Sangtawesin C, Raksasinborisut C, et al. Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. J Med Assoc Thai 2006;89:314-321
15. Tiker F, Yildirim SV. Acute renal impairment after oral ibuprofen for medical closure of patent ductus arteriosus. Indian Pediatr 2007;44:54-55
16. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics 2003;112:e354
17. Müller P, Simon B. Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers. Arzneimittelforschung 1994;44:840-843